StockData

Canopy Growth vs Organigram Global

CGC and OGI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CGC and OGI compare

Organigram Global grew revenue faster over the last twelve months (77.8% versus 6.8% for Canopy Growth).

Organigram Global scores higher on the StockData Score (4 against 3 for Canopy Growth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCGCOGI
Size and price
Share price$0.531$0.707
Change, 1 year−50.3%−53.2%
Change, 5 years−99.5%−91.8%
Beta (5Y)1.231.27
Employees1,128–
StockData Score
Total score34 (better)
Valuation score00
Growth score13 (better)
Performance score1 (better)0
Health score11
Dividend score00
Growth
Revenue growth (TTM)6.8%77.8% (better)
Revenue growth, 5Y average−12.2%83.6% (better)
Profitability
Gross margin25.2%34.8% (better)
Operating margin−54.9%−5.9% (better)
Net margin−79.2%–
FCF margin−28.3%−9.5% (better)
Financial health
Net debt / EBITDA–−31.24
Interest coverage−3.9×–
Current ratio3.04 (better)2.26
Piotroski F-score5–
Ownership
Held by institutions6.9%5.7%
Held by insiders1.0%31.4%
Insider net buying, 12 months−$393K–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.